(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
about
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsFunctional imaging in adult and paediatric brain tumours.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Magnetic Resonance (MR) Metabolic Imaging in Glioma.Interrogating Metabolism in Brain Cancer.Advances in MRI assessment of gliomas and response to anti-VEGF therapy.Utility of multiparametric 3-T MRI for glioma characterizationAdvances in neuro-oncology imaging.Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands.Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.Physiological effects of cigarette smoking in the limbic system revealed by 3 tesla magnetic resonance spectroscopy.
P2860
Q26853516-B89CCB4B-03EE-4065-8002-5568FAE279ADQ30577397-302AACCF-3B57-4DF6-9E94-947DF4391443Q30967370-A90A5657-391D-469F-98CD-9C19BB07F780Q31015256-72C600BD-7D9D-4A26-8F97-B65D3A833582Q31136705-2E99DBD1-AB34-4B9D-B630-FAB936DC6275Q33793253-CB2D1F3F-DD23-4DEE-BC59-15DD3C5D01BCQ34404713-C1E8ADB7-409C-4250-A339-EF45C7A0E1FDQ36339461-3D18A4F6-4E0F-4D7D-92E0-0F035AE4DB9EQ41220218-E03D1E7D-DFDB-48E6-BF70-661F4849117DQ41935740-73E7325A-0FB6-4926-B598-C3C9906A4CF9Q43413739-13442FF6-B044-4F35-9B11-B8680BBB7D8BQ52304295-A524EBCC-C948-4293-BFB2-16776FBE089B
P2860
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
@en
type
label
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
@en
prefLabel
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
@en
P2093
P2860
P1476
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
@en
P2093
Elke Hattingen
Heinrich Lanfermann
Oliver Delic
Peter Raab
Rüdiger Gerlach
Ulrich Pilatus
P2860
P304
P356
10.1179/016164109X12478302362770
P577
2009-09-01T00:00:00Z